Biotech Values

[DewDiligence]

>> Listened to OXGN, Driscoll stumbled over when they would actually file the IND for Oxi4503. Rodman and Renshaw asked if they would be enrolling by yearend....uhhh, ummmm, animal testing is nearing completion, ummm we uhhh depends on the FDA regulatory authority...ummm. <<

We know that OXGN feeds investors a lot of BS. The question is whether GENR does the same. Some of the GENR’s R&R presentation regarding the 10mg dose did not entirely ring true. I am trying to figure out what it all means.

>> Congrats on the Red Sox… Did you get any sleep at all? <<

No, but I never do.